Derimap 84.7mg/25.3mg Injection
Marketer
Skymap Pharmaceutical Pvt Ltd
Salt Composition
Etofylline (84.7mg) + Theophylline (25.3mg)
Overview Derimap 84.7mg/25.3mg Injection
AirDuo 84.7mg/25.3mg injection is indicated for managing asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by airflow obstruction. Its mechanism involves bronchial muscle relaxation, facilitating improved breathing. Administration is by a healthcare professional, with dosage tailored to individual patient needs and response. Continued use, as directed by your physician, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is essential due to potential interactions. Commonly reported side effects include nausea, vomiting, dyspepsia, headache, and agitation; these are generally transient and self-limiting. Prompt medical consultation is advised for any concerning side effects. Prior to treatment initiation, inform your doctor of any pre-existing cardiac, renal, or hepatic conditions to ensure appropriate dosage selection. Similarly, disclose pregnancy, pregnancy intentions, or breastfeeding status.
Primary Ingredients of Derimap 84.7mg/25.3mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Derimap 84.7mg/25.3mg Injection
Managing chronic obstructive pulmonary disease (COPD)
Major Benefits of Derimap 84.7mg/25.3mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Derimap 84.7mg/25.3mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Derimap 84.7mg/25.3mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Derimap 84.7mg/25.3mg Injection works:
Etofylline and theophylline, combined in Derimap 84.7mg/25.3mg Injection, act as dual bronchodilators. Their mechanism involves airway muscle relaxation, leading to expanded airways and improved breathing.
SAFETY ADVICE
AlcoholUNSAFE
Combining Derimap 84.7mg/25.3mg Injection with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Derimap 84.7mg/25.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The injectable medication, Derimap 84.7mg/25.3mg, is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant. Post-injection, a 2-4 hour delay in breastfeeding may further reduce the infant's exposure to the medicine.
DrivingCONSULT YOUR DOCTOR
Derimap 84.7mg/25.3mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Derimap 84.7mg/25.3mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Derimap 84.7mg/25.3mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Derimap 84.7mg/25.3mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Derimap 84.7mg/25.3mg Injection :
Omitting a scheduled dose of Derimap 84.7mg/25.3mg Injection necessitates contacting your physician.
Facts to Know About Derimap 84.7mg/25.3mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
3,018 People bought this recently